Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1958 Nov 1;108(5):591-604.
doi: 10.1084/jem.108.5.591.

The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon

The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon

C G COCHRANE et al. J Exp Med. .

Abstract

The in vivo activity of soluble antigen-antibody complexes was tested by a single intradermal injection in rabbits. Skin reactions were obtained marked by erythema, induration, and occasionally hemorrhage and necrosis. Microscopically, diffuse inflammation and occasional vascular necrosis could be found at all dosages. This indicates that soluble antigen-antibody complexes are phlogogenic and provides support for the suggestion that complexes are responsible for the lesions seen in serum sickness. The reactions were similar in severity to local passive Arthus (LPA) reactions at equal dosages of antibody in the dosage range studied. BSA antigen could be found in large concentrations in affected vessel walls of both reverse passive Arthus (RPA) and active or classical Arthus reactions. It is suggested that this predominantly vascular localization of antigen might bring about the relative severity of the RPA and active Arthus reactions, as contrasted to the complex and LPA reactions. The finding of affected vessels in the complex and LPA reactions containing little or no antigen and antibody, while these components were present in adjacent areas, suggests that the antigen-antibody combination may cause vascular reaction and damage by the release of physiologically active mediators from the tissue or tissue fluid.

PubMed Disclaimer

References

    1. J Exp Med. 1953 Feb 1;97(2):257-82 - PubMed
    1. J Immunol. 1953 Apr;70(4):345-51 - PubMed
    1. Proc Soc Exp Biol Med. 1952 Dec;81(3):584-6 - PubMed
    1. J Immunol. 1953 Jul;71(1):6-11 - PubMed
    1. Int Arch Allergy Appl Immunol. 1954;5(1):23-46 - PubMed